- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Geographic atrophy (GA) secondary to age-related macular degeneration (AMD)
- Meeting Date: March 2026
- Public Summary Document (PSD) March 2026 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2026 PBAC Meeting - (DOCX)
Avacincaptad Pegol – March 2026
Solution for intravitreal injection 2 mg in 0.1 mL (20 mg per mL)
Last updated
11 March 2026